WallStreetZenWallStreetZen

NASDAQ: ORIC
Oric Pharmaceuticals Inc Stock Ownership - Who owns Oric Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Oric Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Richard A. HeymanDirector2026-01-163,500$12.01
$42.02kSell
Richard A. HeymanDirector2026-01-163,200$12.01
$38.42kSell
Pratik S. MultaniChief Medical Officer2025-12-1610,720$9.06
$97.12kSell
Jacob ChackoPRESIDENT AND CEO2025-12-1633,374$9.06
$302.37kSell
Dominic PiscitelliChief Financial Officer2025-12-1610,720$9.06
$97.12kSell
Lori Anne KunkelDirector2025-12-0810,000$7.90
$79.00kBuy
Lori Anne KunkelDirector2025-12-045,534$3.75
$20.75kBuy
Dominic PiscitelliChief Financial Officer2025-10-0611,000$14.52
$159.72kSell
Jacob ChackoPRESIDENT AND CEO2025-10-0637,461$12.32
$461.52kSell
Dominic PiscitelliChief Financial Officer2025-10-0611,000$4.36
$47.96kBuy

1 of 3

ORIC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ORIC insiders and whales buy or sell their stock.

ORIC Shareholders

What type of owners hold Oric Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Nextech Invest Ltd7.35%7,162,637$74.63MInstitution
Ecor1 Capital LLC6.91%6,728,116$70.11MInstitution
Vr Adviser LLC6.77%6,596,885$68.74MInstitution
Viking Global Investors LP6.75%6,572,700$68.49MInstitution
Pfizer Inc5.52%5,376,344$56.02MInsider
Pfizer Inc5.52%5,376,344$56.02MInstitution
Blackrock Inc5.42%5,276,620$54.98MInstitution
Peter Svennilson4.90%4,768,181$49.68MInsider
Vanguard Group Inc4.77%4,650,138$48.45MInstitution
Sr One Capital Management LP4.64%4,514,929$47.05MInstitution

1 of 3

ORIC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ORIC83.26%16.74%Net SellingNet Selling
NBTX11.70%0.00%
IOVA16.41%83.59%Net SellingNet Selling
VIR67.52%32.48%Net SellingNet Selling
URGN81.40%18.60%Net SellingNet Selling
View Top Biotech Stocks

Oric Pharmaceuticals Stock Ownership FAQ

Who owns Oric Pharmaceuticals?

Oric Pharmaceuticals (NASDAQ: ORIC) is owned by 109.35% institutional shareholders, 21.98% Oric Pharmaceuticals insiders, and 0.00% retail investors. Pfizer Inc is the largest individual Oric Pharmaceuticals shareholder, owning 5.38M shares representing 5.52% of the company. Pfizer Inc's Oric Pharmaceuticals shares are currently valued at $56.02M.

If you're new to stock investing, here's how to buy Oric Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.